Cargando…
Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid
Bullous pemphigoid (BP) is a chronic subepidermal immunobullous disorder. Studies have demonstrated the presence of antibasement membrane zone antibodies (BP180 & BP230) in the blister fluid using enzyme-linked immunosorbent assay (ELISA). To detect and compare BP 180 and BP 230 autoantibodies i...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162740/ https://www.ncbi.nlm.nih.gov/pubmed/37151247 http://dx.doi.org/10.4103/ijd.ijd_248_22 |
_version_ | 1785037757451599872 |
---|---|
author | Nagarajan, Harish Mahadevan, Krishnaswamy Rai, Reena Boppe, Appalaraju |
author_facet | Nagarajan, Harish Mahadevan, Krishnaswamy Rai, Reena Boppe, Appalaraju |
author_sort | Nagarajan, Harish |
collection | PubMed |
description | Bullous pemphigoid (BP) is a chronic subepidermal immunobullous disorder. Studies have demonstrated the presence of antibasement membrane zone antibodies (BP180 & BP230) in the blister fluid using enzyme-linked immunosorbent assay (ELISA). To detect and compare BP 180 and BP 230 autoantibodies in the blister fluid and serum of patients with BP by ELISA method. A total of 30 patients diagnosed as BP and not on treatment were included in the study. Blister fluid and serum were subjected to ELISA, and the results were compared. The sensitivity of ELISA BP 180 was found to be 95.8% in the blister fluid and 88.4% in the serum. The sensitivity of ELISA BP 230 in the blister fluid and serum was 20% and 16.6%, respectively. Association between ELISA antibodies done in blister and serum was analysed using Chi-square test and found to be statistically significant with P value <0.05. Blister fluid is an effective alternative to the serum in detecting BP 180 and BP 230 antibodies, especially in uncooperative and elderly patients with poor venous access. |
format | Online Article Text |
id | pubmed-10162740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-101627402023-05-06 Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid Nagarajan, Harish Mahadevan, Krishnaswamy Rai, Reena Boppe, Appalaraju Indian J Dermatol Short Communication Bullous pemphigoid (BP) is a chronic subepidermal immunobullous disorder. Studies have demonstrated the presence of antibasement membrane zone antibodies (BP180 & BP230) in the blister fluid using enzyme-linked immunosorbent assay (ELISA). To detect and compare BP 180 and BP 230 autoantibodies in the blister fluid and serum of patients with BP by ELISA method. A total of 30 patients diagnosed as BP and not on treatment were included in the study. Blister fluid and serum were subjected to ELISA, and the results were compared. The sensitivity of ELISA BP 180 was found to be 95.8% in the blister fluid and 88.4% in the serum. The sensitivity of ELISA BP 230 in the blister fluid and serum was 20% and 16.6%, respectively. Association between ELISA antibodies done in blister and serum was analysed using Chi-square test and found to be statistically significant with P value <0.05. Blister fluid is an effective alternative to the serum in detecting BP 180 and BP 230 antibodies, especially in uncooperative and elderly patients with poor venous access. Wolters Kluwer - Medknow 2023 /pmc/articles/PMC10162740/ /pubmed/37151247 http://dx.doi.org/10.4103/ijd.ijd_248_22 Text en Copyright: © 2023 Indian Journal of Dermatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Short Communication Nagarajan, Harish Mahadevan, Krishnaswamy Rai, Reena Boppe, Appalaraju Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid |
title | Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid |
title_full | Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid |
title_fullStr | Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid |
title_full_unstemmed | Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid |
title_short | Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid |
title_sort | evaluation of elisa bp180 and bp230 autoantibodies in blister fluid and serum in the diagnosis of bullous pemphigoid |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162740/ https://www.ncbi.nlm.nih.gov/pubmed/37151247 http://dx.doi.org/10.4103/ijd.ijd_248_22 |
work_keys_str_mv | AT nagarajanharish evaluationofelisabp180andbp230autoantibodiesinblisterfluidandseruminthediagnosisofbullouspemphigoid AT mahadevankrishnaswamy evaluationofelisabp180andbp230autoantibodiesinblisterfluidandseruminthediagnosisofbullouspemphigoid AT raireena evaluationofelisabp180andbp230autoantibodiesinblisterfluidandseruminthediagnosisofbullouspemphigoid AT boppeappalaraju evaluationofelisabp180andbp230autoantibodiesinblisterfluidandseruminthediagnosisofbullouspemphigoid |